Literature DB >> 16314466

Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice.

Guohong Li1, John M Sanders, Elizabeth T Phan, Klaus Ley, Ian J Sarembock.   

Abstract

P-selectin expression has been reported in platelets, endothelial cells, and vascular smooth muscle cells in response to vascular injury. Here, we report P-selectin expression on macrophages in the arterial wall after carotid denudation injury and spontaneous atherosclerosis in atherosclerosis-prone apoE-deficient (apoE(-/-)) mice. Double-immunofluorescence staining revealed robust P-selectin expression in macrophage-rich regions of both denudation-induced carotid neointimal lesions and innominate atherosclerotic plaques. Co-localization of P-selectin with macrophages was verified at the single cell level using double immunostaining plus 4,6-diamidino-2-phenylindole (for nuclei) counterstaining. No platelet staining was seen in association with the macrophage staining, excluding platelet contamination. Furthermore, P-selectin mRNA expression was readily detectable in macrophage-rich plaques of atherosclerotic innominate arteries and blood monocyte-derived macrophages from apoE(-/-) mice. Strong P-selectin expression was also seen in the areas of regenerated endothelium after arterial injury. In addition, co-localization of P-selectin with vascular smooth muscle cells was readily observed in denudation-injured carotid arteries at 7 and 14 days. We conclude that macrophages in carotid injury-induced neointimal lesions and spontaneous atherosclerotic plaques of the innominate artery acquire the ability to express P-selectin, as does regenerating endothelium. These findings provide a potential new paradigm in macrophage-mediated vascular inflammation, atherosclerosis, and neointimal hyperplasia after arterial injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314466      PMCID: PMC1613195          DOI: 10.1016/S0002-9440(10)61237-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages.

Authors:  Sergio H Seabra; Wanderley de Souza; Renato A DaMatta
Journal:  Exp Parasitol       Date:  2002-01       Impact factor: 2.011

2.  Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury.

Authors:  S S Smyth; E D Reis; W Zhang; J T Fallon; R E Gordon; B S Coller
Journal:  Circulation       Date:  2001-05-22       Impact factor: 29.690

Review 3.  Macrophage cholesterol transport: a critical player in foam cell formation.

Authors:  Saara Vainio; Elina Ikonen
Journal:  Ann Med       Date:  2003       Impact factor: 4.709

4.  Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

Authors:  Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

5.  Platelet P-selectin facilitates atherosclerotic lesion development.

Authors:  Peter C Burger; Denisa D Wagner
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

6.  Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice.

Authors:  A Kumar; J L Hoover; C A Simmons; V Lindner; R J Shebuski
Journal:  Circulation       Date:  1997-12-16       Impact factor: 29.690

7.  Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein-E-deficient mice.

Authors:  D R Manka; P Wiegman; S Din; J M Sanders; S A Green; L W Gimple; M Ragosta; E R Powers; K Ley; I J Sarembock
Journal:  J Vasc Res       Date:  1999 Sep-Oct       Impact factor: 1.934

8.  Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice.

Authors:  J William Phillips; Kurt G Barringhaus; John M Sanders; Sean E Hesselbacher; Ann C Czarnik; David Manka; Dietmar Vestweber; Klaus Ley; Ian J Sarembock
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

9.  Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.

Authors:  Samuel Joseph Leibovich; Jiang-Fan Chen; Grace Pinhal-Enfield; Paula C Belem; Genie Elson; Anthony Rosania; Madhuri Ramanathan; Carmen Montesinos; Marlene Jacobson; Michael A Schwarzschild; J Stephen Fink; Bruce Cronstein
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 10.  The role of selectins in inflammation and disease.

Authors:  Klaus Ley
Journal:  Trends Mol Med       Date:  2003-06       Impact factor: 11.951

View more
  16 in total

1.  Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro.

Authors:  Guohong Li; Suzanne Oparil; John M Sanders; Lin Zhang; Meiru Dai; Lan Bo Chen; Simon J Conway; Coleen A McNamara; Ian J Sarembock
Journal:  Atherosclerosis       Date:  2005-12-01       Impact factor: 5.162

2.  CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.

Authors:  Guohong Li; John M Sanders; Melissa H Bevard; Zhiqi Sun; James W Chumley; Elena V Galkina; Klaus Ley; Ian J Sarembock
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

3.  P-Selectin Expressed by a Human SELP Transgene Is Atherogenic in Apolipoprotein E-Deficient Mice.

Authors:  Nan Zhang; Zhenghui Liu; Longbiao Yao; Padmaja Mehta-D'souza; Rodger P McEver
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-21       Impact factor: 8.311

4.  Glycosyltransferases involved in the synthesis of MUC-associated metastasis-promoting selectin ligands.

Authors:  Vishwanath B Chachadi; Ganapati Bhat; Pi-Wan Cheng
Journal:  Glycobiology       Date:  2015-05-13       Impact factor: 4.313

Review 5.  Update on the role of endothelial cells in trauma.

Authors:  J Greven; R Pfeifer; Q Zhi; H C Pape
Journal:  Eur J Trauma Emerg Surg       Date:  2017-07-03       Impact factor: 3.693

6.  L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicide.

Authors:  Maohua Zhong; Benxia He; Jingyi Yang; Rong Bao; Yan Zhang; Dihan Zhou; Yaoqing Chen; Liangzhu Li; Chen Han; Yi Yang; Ying Sun; Yuan Cao; Yaoming Li; Wei Shi; Shibo Jiang; Xiaoyan Zhang; Huimin Yan
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 7.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.

Authors:  Armen Yuri Gasparyan; Antonios Stavropoulos-Kalinoglou; Dimitri P Mikhailidis; Karen M J Douglas; George D Kitas
Journal:  Rheumatol Int       Date:  2011-02       Impact factor: 2.631

8.  PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.

Authors:  Y Zheng; J Yang; J Qian; P Qiu; S Hanabuchi; Y Lu; Z Wang; Z Liu; H Li; J He; P Lin; D Weber; R E Davis; L Kwak; Z Cai; Q Yi
Journal:  Leukemia       Date:  2012-09-21       Impact factor: 11.528

9.  Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice.

Authors:  Huan Wang; Weiyu Zhang; Rong Tang; Chuhong Zhu; Christoph Bucher; Bruce R Blazar; Jian-Guo Geng; Chunxiang Zhang; Joel Linden; Chaodong Wu; Yuqing Huo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-18       Impact factor: 8.311

10.  P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice.

Authors:  Guangyu An; Huan Wang; Rong Tang; Tadayuki Yago; J Michael McDaniel; Samuel McGee; Yuqing Huo; Lijun Xia
Journal:  Circulation       Date:  2008-06-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.